+ All Categories
Home > Documents > Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of...

Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of...

Date post: 22-Dec-2015
Category:
Upload: erick-maxwell
View: 213 times
Download: 0 times
Share this document with a friend
Popular Tags:
29
Drug delivery systems Michael G. Stewart, MD, MPH Michael G. Stewart, MD, MPH Professor and Chairman Professor and Chairman Department of Otorhinolaryngology Department of Otorhinolaryngology
Transcript
Page 1: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Drug delivery systems

Michael G. Stewart, MD, MPHMichael G. Stewart, MD, MPHProfessor and ChairmanProfessor and Chairman

Department of OtorhinolaryngologyDepartment of Otorhinolaryngology

Page 2: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Paranasal sinuses & middle ear

• Frequent sites of infection, inflammationFrequent sites of infection, inflammation• Lined by mucous membrane (mucosa) with Lined by mucous membrane (mucosa) with

good capacity for absorptiongood capacity for absorption• Current surgical managementCurrent surgical management

• Opening, ventilation, irrigationOpening, ventilation, irrigation

• Potential problems & issuesPotential problems & issues• Access to cavityAccess to cavity• Maintenance of medication doseMaintenance of medication dose

Page 3: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Other potential locations

• Into abdominal cavityInto abdominal cavity• Into chest cavityInto chest cavity• Intra-vascularIntra-vascular• Directly into tissue, joint, muscleDirectly into tissue, joint, muscle

Page 4: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Sinus: clinical diseases

• Chronic inflammatory sinus diseaseChronic inflammatory sinus disease• Chronic infectionChronic infection• Nasal polypsNasal polyps• Fungal sinusitisFungal sinusitis• Cystic fibrosisCystic fibrosis• Other diseases of mucus and cilia transportOther diseases of mucus and cilia transport

Page 5: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Paranasal sinus anatomy

Page 6: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.
Page 7: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Normal sinus CT

Page 8: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.
Page 9: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.
Page 10: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.
Page 11: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Normal middle turbinate, left side

Page 12: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Nasal polyps

Page 13: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Large nasal polyp

Page 14: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Endoscopic sinus surgery

Page 15: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Endoscopic sinus surgery

Page 16: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.
Page 17: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.
Page 18: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Endoscopic sinus surgery video

Page 19: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Problems – sinus disease

• Access to sinus cavitiesAccess to sinus cavities• Mucosa is source of inflammation, polyp Mucosa is source of inflammation, polyp

regrowthregrowth• Inhaled solutions go directly to back of noseInhaled solutions go directly to back of nose• Irrigated solutions go partially into some Irrigated solutions go partially into some

sinusessinuses• Oral or intravenous meds go to mucosaOral or intravenous meds go to mucosa

• Problems with long-term use of steroids Problems with long-term use of steroids and antibiotics, antifungal meds and antibiotics, antifungal meds

Page 20: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Problems – sinus disease 2

• Fungal particles trapped in sinus cavityFungal particles trapped in sinus cavity• ““inside the sinus, outside the body”inside the sinus, outside the body”• Surgery to ventilate sinus is only part of Surgery to ventilate sinus is only part of

solutionsolution• Bacterial overgrowth in sinus cavityBacterial overgrowth in sinus cavity• Impairment in mucus, cilia functionImpairment in mucus, cilia function

Page 21: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Potential solutions - sinuses

• Topical delivery systemTopical delivery system• Implantable delivery systemImplantable delivery system• Slow-dissolving “gel” into sinus?Slow-dissolving “gel” into sinus?• Positive pressure aerosol?Positive pressure aerosol?• Other method of delivery Other method of delivery

• Long-term dosing directly to areaLong-term dosing directly to area• High topical dose, limited systemic absorptionHigh topical dose, limited systemic absorption• Constant dosingConstant dosing

Page 22: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Ear anatomy

Page 23: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Ear disease

• Middle earMiddle ear• Persistent effusionPersistent effusion• Recurrent infection or effusionRecurrent infection or effusion• Eustachian tube blockEustachian tube block

Page 24: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Ear disease

• Inner earInner ear – middle ear could be source of – middle ear could be source of drug deliverydrug delivery• Meniere’s disease (recurrent vertigo)Meniere’s disease (recurrent vertigo)• Autoimmune inner ear disease Autoimmune inner ear disease • Sudden hearing lossSudden hearing loss• Ototoxic systemic medicationsOtotoxic systemic medications• Noise traumaNoise trauma

Page 25: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Normal eardrum

Page 26: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Middle ear effusion

Page 27: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Issues – ear disease

• Easier accessEasier access• ProblemsProblems

• requires puncturing eardrumrequires puncturing eardrum• requires multiple procedures, dosesrequires multiple procedures, doses• long-term problems, want preventative long-term problems, want preventative

treatment in some cases treatment in some cases

Page 28: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Delivery system

• Prolonged releaseProlonged release• Steady dosing (not bolus)Steady dosing (not bolus)• Remain in situRemain in situ• Not interfere with hearingNot interfere with hearing

Page 29: Drug delivery systems Michael G. Stewart, MD, MPH Professor and Chairman Department of Otorhinolaryngology.

Summary

• Paranasal sinus and ear disease are very Paranasal sinus and ear disease are very common problemscommon problems

• Can get access to site of disease Can get access to site of disease • Need better long-term delivery and Need better long-term delivery and

distribution of medication dosesdistribution of medication doses


Recommended